Article | April 24, 2023

Deliver A Technical Package That Serves On-Time Injectable Project Completion

Source: Singota Solutions

By William Powers, Singota Solutions

Bio Manufacturing GettyImages-1219894348

The accuracy, robustness, and completeness of the technical package an organization submits to its development and/or manufacturing partner is critical to meeting fill project timelines. A detailed conversation at project outset between the scientists who completed formulation work and the CDMO avoids many such issues, or at least prepares both parties for potential problems.

First-time development projects are among the most susceptible to these issues. Smaller or emerging organizations may be less prepared due to smaller staffs and fewer resources, while larger companies have the benefit of more SMEs and more available resources. The heavy lifting of early drug development work is increasingly handled by small companies, which lack the benefit of a huge stable of scientists, have stakeholders to appease, and — almost always — work under the cloud of an ambitious timeline. This can lead to a technical package that is not as complete and accurate as both partners would prefer. Issues exposed during fill/finish typically are related to three areas: analytical test methods, formulation, and drug substance.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Delivery Leader